M04.8
Other autoinflammatory syndromes
Clinical Classification Guidelines
Inclusion Terms
- Blau syndrome
- Deficiency of interleukin 1 receptor antagonist [DIRA]
- Majeed syndrome
- Periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome [PFAPA]
- Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome [PAPA]
Medical Intelligence & Overview
Other autoinflammatory syndromes encompass a diverse group of disorders characterized by recurrent episodes of inflammation without a clear infectious or autoimmune cause. These conditions often involve genetic factors and affect multiple organs, leading to symptoms such as fever, skin rashes, and joint pain. Under ICD-10 code M04.8, several specific syndromes are categorized, including Blau syndrome, DIRA, Majeed syndrome, PFAPA, and PAPA syndrome. Recognizing these syndromes is crucial for appropriate diagnosis and management, although medical consultation is essential for any suspected condition.
Causes & Symptoms
Clinical Causes: Genetic mutations that affect inflammatory pathways Inherited gene alterations influencing immune response Deficiencies or overactivation of specific cytokines, such as interleukin-1 Autosomal dominant or recessive inheritance patterns in some syndromes Environmental factors generally play a limited role but may influence disease expression
Key Symptoms: Recurrent fever episodes Skin manifestations such as rashes, pustules, or ulcers Joint pain, swelling, or arthritis Mucous membrane inflammation including stomatitis and pharyngitis Swollen lymph nodes (adenopathy) Muscle and bone pain Other systemic signs like fatigue and malaise
Diagnostic & Treatment
Diagnosis Path: Detailed medical history emphasizing symptom patterns and family history Physical examination focusing on skin, joints, and lymph nodes Laboratory tests such as inflammatory markers (ESR, CRP) Genetic testing to identify specific mutations associated with syndromes Imaging studies in some cases to assess joint and organ involvement
Treatment Protocols: Nonsteroidal anti-inflammatory drugs (NSAIDs) to alleviate joint and systemic inflammation Corticosteroids for acute flares or severe symptoms Biologic agents targeting specific cytokines, particularly interleukin-1 inhibitors like anakinra Immunosuppressive medications in certain cases Supportive therapies such as physical therapy and skin care Regular monitoring for potential complications
Clinical Advice & FAQs
Billing Guidance
Is M04.8 a billable ICD-10 code?
Yes, M04.8 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M04.8?
Clinical documentation must specify the nature of Other autoinflammatory syndromes and any associated comorbidities for accurate reporting.
Cite this Clinical Reference